大理大学学报 ›› 2021, Vol. 6 ›› Issue (8): 44-46.DOI: 10. 3969 / j. issn. 2096-2266. 2021. 08. 009

• 药学 • 上一篇    下一篇

替加环素治疗重症肺炎患者的不良反应及其影响因素分析

涂雄文   

  1. (皖南医学院弋矶山医院,安徽芜湖 241001)
  • 收稿日期:2020-12-17 修回日期:2021-03-07 出版日期:2021-08-15 发布日期:2021-09-28
  • 作者简介:涂雄文,副主任医师,主要从事呼吸及危重症医学研究。

Analysis of Adverse Reactions and Influencing Factors of Tigecycline in the Treatment of Severe Pneumonia

Tu Xiongwen   

  1. (Yijishan Hospital, Wannan Medical College, Wuhu, Anhui 241001, China)
  • Received:2020-12-17 Revised:2021-03-07 Online:2021-08-15 Published:2021-09-28

摘要: 目的:分析替加环素治疗重症肺炎患者的不良反应及其影响因素。方法:选择2019 年7 月至2020 年6 月在皖南医学
院弋矶山医院行替加环素治疗的重症肺炎患者124 例,统计相关临床数据,通过对发生不良反应和未发生不良反应患者的不同
指标进行分析,了解替加环素不良反应的影响因素。结果:124 例患者出现不良反应35 例,发生率为28.23%,其中肝功能损
伤12 例,皮疹2 例,水肿1 例,血小板药物性降低10 例,消化系统问题9 例,血小板降低并肝功能损伤1 例。与未发生不良
反应的患者相比,发生不良反应患者的年龄、丙氨酸氨基转移酶(ALT)、高血压、吸烟、锻炼差异有统计学意义(P < 0.05);
而性别、体质指数(BMI)、喝酒、天冬氨酸氨基转移酶(AST)差异无统计学意义(P > 0.05)。结论:替加环素治疗重症肺
炎患者的不良反应主要是水肿、肝功能损伤、皮疹、血小板降低、血小板降低并肝功能损伤,不良反应的发生与患者年龄、
ALT、高血压、吸烟、锻炼有关。

关键词: 替加环素, 重症肺炎, 不良反应, 影响因素

Abstract: Objective: To analyze the adverse reactions and influencing factors of tigecycline in the treatment of severe pneumonia.
Methods: 124 patients with severe pneumonia who were treated with tigecycline in Yijishan Hospital,Wannan Medical College from
July 2019 to June 2020 were selected, and the relevant clinical data were counted. Through the analysis of different indexes of patients
with and without adverse reations, the influencing factors of adverse reactions of tigecycline were understood. Results: Among the 124
patients, 35 cases had adverse reactions, the incidence rate was 28.23%, including 12 cases of liver function injury, 2 cases of rash, 1
cases of edema, 10 cases of drug-induced thrombocytopenia, 9 cases of digestive system problems, 1 cases of thrombocytopenia and
liver function injury. There were significant differences in age, alanine aminotransferase (ALT), high blood pressure, smoking
and exercise between patients with and without adverse reactions (P< 0.05), but there were no significant differences in gender, body
mass index (BMI), drinking and aspartate aminotransferase (AST) (P> 0.05). Conclusion: The main adverse reactions of tigecycline
in the treatment of severe pneumonia are edema, liver function damage, rash, thrombocytopenia, thrombocytopenia and liver function
damage. The occurrence of adverse reactions is related to the patient s age, ALT, high blood pressure, smoking and exercise.

Key words: tigecycline, severe pneumonia, adverse reactions, influencing factor

中图分类号: